Exact Sciences
EXAS
#1381
Rank
NZ$21.15 B
Marketcap
$114.49
Share price
2.34%
Change (1 day)
-9.41%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2023 (TTM): -$2.53

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -$2.56. In 2022 the company made an earnings per share (EPS) of -$5.72 a decrease over its 2021 EPS that were of -$5.59.

EPS history for Exact Sciences from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.53-55.77%
2022-$5.722.31%
2021-$5.59-37.09%
2020-$8.89674.65%
2019-$1.15-50.69%
2018-$2.3344%
2017-$1.62-39.39%
2016-$2.67-2.94%
2015-$2.7537.1%
2014-$2.0079.71%
2013-$1.12-21.59%
2012-$1.4262.96%
2011-$0.8792.86%
2010-$0.45-3.45%
2009-$0.47-19.44%
2008-$0.58-18.18%
2007-$0.71-10.2%
2006-$0.79-10.91%
2005-$0.89-24.66%
2004-$1.18-51.33%
2003-$2.42-7.41%
2002-$2.6211.72%
2001-$2.34

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$4.91 91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.55-121.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.65-74.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-$82.27 3,110.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.14-300.57%๐Ÿ‡ซ๐Ÿ‡ท France